Tokyo, April 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061040) titled 'Validation of atrial fibrillation screening strategies in patients with ischemic heart disease using artificial intelligence electrocardiography (CVI ARO 21 Study)' on April 1.
Study Type:
Observational
Primary Sponsor:
Institute - The Cardiovascular Institute
Condition:
Condition - Ischemic heart disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To Evaluate the availability of seal-designed Holter ECG in patients with ischemic disease and high risk for atrial fibrillation by real-time risk alert derived from artificial intelligence enhanced sinus rhythm ECG...